切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2023, Vol. 17 ›› Issue (04) : 320 -324. doi: 10.11817/j.issn.1673-9248.2023.04.003

论著

单纯经胸超声心动图引导卵圆孔未闭封堵术早期安全性及有效性分析
姜新鹏, 李晓明, 杨航, 宫一宸, 傅元豪, 傅瑜(), 张喆()   
  1. 100191 北京大学第三医院心脏外科
    100191 北京大学第三医院神经科
    100029 首都医科大学附属北京安贞医院介入超声科
  • 收稿日期:2023-07-01 出版日期:2023-08-01
  • 通信作者: 傅瑜, 张喆
  • 基金资助:
    北京大学第三医院院临床重点项目(BYSYZD2022034)

Evaluation of the safety and efficacy of patent foramen ovale closure guided by transthoracic echocardiography

Xinpeng Jiang, Xiaoming Li, Hang Yang, Yichen Gong, Yuanhao Fu, Yu Fu(), Zhe Zhang()   

  1. Department of Cardiology, Peking University Third Hospital, Beijing 100191, China
    Department of Interventional Ultrasound, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
    Department of Neurology, Peking University Third Hospital, Beijing 100191, China
  • Received:2023-07-01 Published:2023-08-01
  • Corresponding author: Yu Fu, Zhe Zhang
引用本文:

姜新鹏, 李晓明, 杨航, 宫一宸, 傅元豪, 傅瑜, 张喆. 单纯经胸超声心动图引导卵圆孔未闭封堵术早期安全性及有效性分析[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 320-324.

Xinpeng Jiang, Xiaoming Li, Hang Yang, Yichen Gong, Yuanhao Fu, Yu Fu, Zhe Zhang. Evaluation of the safety and efficacy of patent foramen ovale closure guided by transthoracic echocardiography[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(04): 320-324.

目的

分析单纯经胸超声心动图(TTE)引导卵圆孔未闭(PFO)封堵术的早期安全性及有效性。

方法

回顾性分析2019年3月至2022年12月于北京大学第三医院行TTE引导PFO封堵术的患者资料,共纳入403例,其中脑卒中患者145例,偏头痛患者258例。观察围手术期及术后3个月严重手术并发症及脑卒中/短暂性脑缺血发作是否复发,评估手术的安全性;采用配对t检验比较术前及术后3个月偏头痛患者的缓解程度[头痛影响测评量表6(HIT6)评分、头痛持续时间、头痛发作频率],评估手术的有效性。

结果

403例PFO封堵术患者中,20例患者因鞘管无法通过而终止手术,手术成功率为95.04%(383/403);手术时间为(23.3±7.3)min;在严重手术并发症方面,发生心包积液者13例(3.23%,13/403)、冠状动脉气体栓塞者4例(0.99%,4/403),未见封堵器脱落移位、外周血管损伤等并发症。4例冠状动脉气体栓塞患者经对症处理后好转;13例心包积液患者中,11例经心包穿刺引流后好转,2例紧急开胸探查止血,术中发现均为左心耳穿孔,经对症处理后好转出院。所有患者完成术后3个月随访,未发现封堵器移位、心包积液、主动脉瓣关闭不全等并发症;脑卒中患者未发现脑卒中/短暂性脑缺血发作复发;偏头痛患者术后3个月HIT6评分、头痛发作频率、发作时间较术前均明显减少[(43.6±5.6)分vs(57.8±6.7)分;(2.4±0.6)次/月vs(6.4±2.3)次/月;(2.2±1.4)h/次vs(7.4±4.5)h/次],差异具有统计学意义(t=25.45、26.34、17.27,P均<0.001)。

结论

单纯TTE引导PFO封堵术是安全、有效的。

Objective

To analyze the early safety and efficacy of patent foramen ovale (PFO) occlusion guided by transthoracic echocardiography (TTE).

Methods

The data of 403 patients who underwent TTE-guided PFO occlusion in our hospital from March 2019 to December 2022 were analyzed retrospectively, including 145 patients with stroke and 258 with migraine. We observed the severe surgical complications, the recurrence of stroke/TIA during perioperative period and 3 months after operation, and evaluated their safety; We compared the remission degree of migraine (headache impact test 6[HIT6], frequency and time of headache attack) by paired t-test before and 3 months after operation, and evaluated its effectiveness.

Results

403 cases of PFO occlusion were completed, and 20 patients stopped the operation because the sheath could not pass through, with a success rate of 95.04% (383/403). The average operation time was (23.3±7.3)min. In terms of severe surgical complications, there were 13 cases of pericardial effusion (3.23%, 13/403) and 4 cases of coronary gas embolism (0.99%, 4/403), and no complications such as the loss and displacement of occluder and peripheral vascular injury were found. 4 cases of coronary gas embolism improved after symptomatic treatment; Among 13 cases of pericardial effusion, 11 cases got better after pericardiocentesis and drainage, and 2 cases underwent emergency thoracotomy to stop bleeding. All cases were found to be left atrial appendage perforation during operation, and they were discharged after symptomatic treatment. All patients were followed up for 3 months after operation, and no complications such as occluder displacement, pericardial effusion and aortic valve insufficiency were found. No recurrence of stroke/TIA was found in stroke patients; Three months after operation, the average HIT6 score of migraine patients was (43.6±5.6), the average frequency of headache attack was (2.4±0.6) times/month, and the average attack time was (2.2±1.4) hours/time, which was significantly lower than that before operation [(43.6±5.6) scores vs (57.8±6.7) scores; (2.4±0.6) vs (6.4±2.3); (2.2±1.4) vs (7.4±4.5); t=25.45, 26.34, 17.27; all P<0.001].

Conclusion

TTE-guided PFO occlusion is safe and effective.

图1 单纯经胸超声引导卵圆孔未闭封堵术关键操作的超声影像。图a示鞘管到达下腔静脉开口,箭头示鞘管位置;图b鞘管到达卵圆窝,超声下表现为双轨征,箭头示鞘管位置;图c示鞘管通过卵圆孔,进入左心房,箭头示鞘管位置;图d示打水实验左心房大量气泡,箭头示鞘管位置;图e示左心房伞打开,箭头示左心房伞;图f示右心房伞打开并推拉塑形,箭头示右心房伞注:RV为右心室,LV为左心室,RA为右心房,LA为左心房,AO为主动脉,IVC为下腔静脉
表2 偏头痛患者术前、术后头痛症状及评分对比(
x¯
±s
1
张玉顺, 蒋世良, 朱鲜阳. 卵圆孔未闭相关卒中预防中国专家指南 [J]. 心脏杂志, 2021, 33(1): 1-10.
2
Pristipino C, Sievert H, D'ascenzo F, et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism [J]. Eur Heart J, 2019, 40(38): 3182-3195.
3
Mas JL, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke [J]. N Engl J Med, 2017, 377(11): 1011-1021.
4
Søndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke [J]. N Engl J Med, 2017, 377(11): 1033-1042.
5
Lee PH, Song JK, Kim JS, et al. Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial [J]. J Am Coll Cardiol, 2018, 71(20): 2335-2342.
6
Dowson A, Mullen MJ, Peatfield R, et al. Migraine intervention with STARFlex technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache [J]. Circulation, 2008, 117(11): 1397-1404.
7
Zhang Y, Wang H, Liu L. Patent foramen ovale closure for treating migraine: a meta-analysis [J]. J Interv Cardiol, 2022, 2022: 6456272.
8
中国医师协会神经内科医师分会, 中国研究型医院学会头痛与感觉障碍专业委员会. 中国偏头痛诊治指南(2022版) [J]. 中国疼痛医学杂志, 2022, 28(12): 881-898.
9
Pristipino C, Germonpre P, Toni D, et al. European position paper on the management of patients with patent foramen ovale. Part II-Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions [J]. Eur Heart J, 2021, 42(16): 1545-1553.
10
杨滔, 欧阳文斌, 赵广智, 等. 单纯经胸超声心动图引导下行经皮卵圆孔未闭封堵术的临床研究 [J]. 中国循环杂志, 2019, 34(1): 77-80.
11
唐仕海, 周洋, 刘浪, 等. 单纯经胸超声心动图引导经皮行卵圆孔未闭封堵术的安全性及临床价值分析 [J]. 四川医学, 2022, 43(9): 853-857.
12
周文君, 林进, 姜新鹏, 等. 单纯输送鞘通过法行经胸超声心动引导卵圆孔未闭封堵术的临床疗效分析 [J/OL]. 中华脑血管病杂志(电子版), 2020, 14(2): 100-103.
13
闫一鸣, 欧阳文斌, 张凤文, 等. 中国先天性心脏病介入治疗现状与展望 [J]. 中国胸心血管外科临床杂志, 2022, 29(10): 1243-1253.
14
何璐, 张玉顺. 单中心1336例经导管封堵卵圆孔未闭患者主要并发症回顾性分析 [J]. 中国介入心脏病学杂志, 2019, 27(6): 309-314.
15
Yang T, Butera G, Ou-Yang WB, et al. Percutaneous closure of patent foramen ovale under transthoracic echocardiography guidance-midterm results [J]. J Thorac Dis, 2019, 11(6): 2297-2304.
[1] 薛艳玲, 马小静, 谢姝瑞, 何俊, 夏娟, 何亚峰. 左心声学造影在急性心肌梗死合并室间隔穿孔中的应用价值[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1036-1039.
[2] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[3] 刘中百, 任勇军. 肝细胞癌的介入治疗现状及进展[J]. 中华消化病与影像杂志(电子版), 2023, 13(02): 111-115.
[4] 李世凯, 梁佳, 何艳艳, 于毅, 李天晓, 常金龙, 贺迎坤. 兔颈动脉粥样硬化性狭窄模型在介入治疗的应用进展[J]. 中华介入放射学电子杂志, 2023, 11(04): 357-362.
[5] 张德伟, 雷毅, 江哲宇, 王黎洲, 许国辉, 周石. 杂交手术治疗下肢深静脉血栓合并下肢急性动脉血栓一例[J]. 中华介入放射学电子杂志, 2023, 11(04): 380-384.
[6] 田佳丽, 陈晓波. 卵圆孔未闭隧道特点对介入封堵术的影响因素分析[J]. 中华介入放射学电子杂志, 2023, 11(04): 346-351.
[7] 林加文, 印于, 杨俊, 朱晓黎, 王万胜. 肝动门静脉瘘合并腹水一例[J]. 中华介入放射学电子杂志, 2023, 11(03): 289-291.
[8] 吴雅琴, 莫伟, 向华, 李琴, 李兰. 肝癌患者介入治疗穿刺处出血影响因素的真实世界研究[J]. 中华介入放射学电子杂志, 2023, 11(02): 117-122.
[9] 阴捷, 王驰, 刘玥, 李艳华. 儿童肝脏血管瘤的介入治疗方法及疗效的初步探讨[J]. 中华介入放射学电子杂志, 2023, 11(01): 6-11.
[10] 曾嘉, 何东风. 介入栓塞材料在肝癌治疗中的研究进展[J]. 中华介入放射学电子杂志, 2023, 11(01): 62-67.
[11] 张正宇, 谢兴武, 周雪惠, 陈光斌. DSA引导下经皮动脉栓塞治疗腹壁下动脉出血一例[J]. 中华介入放射学电子杂志, 2023, 11(01): 82-83,88.
[12] 陈丹丹, 潘文志, 陈莎莎, 张源, 张晓春, 李明飞, 周达新, 葛均波. 结构性心脏病年度报告2022[J]. 中华心脏与心律电子杂志, 2023, 11(03): 129-140.
[13] 李燕伟, 黄大军, 伍洲, 张嬿, 康彧, 孔令秋. 曲折的右心声学造影一例[J]. 中华心脏与心律电子杂志, 2023, 11(03): 179-181.
[14] 孙相利, 许真真. 经皮冠状动脉旋磨术在冠状动脉重度钙化病变介入治疗中的应用[J]. 中华老年病研究电子杂志, 2023, 10(02): 33-36.
[15] 尹琛俊, 张喆, 李晓明. 卵圆孔未闭相关血栓形成机制的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 307-311.
阅读次数
全文


摘要